Sara Barrington, CEO of Verici Dx, Russ Mould on activist investors & Glen Goodman on Bitcoin
If you find this podcast useful please give it a rating and review on iTunes by clicking here
On today's Vox Markets Podcast: Sara Barrington, CEO of Verici Dx, Russ Mould on activist investor & Glen Goodman on Bitcoin
Sara Barrington, CEO of immuno-diagnostics development company Verici Dx #VRCI discusses the significant market opportunity and upcoming milestones.
Verici Dx is an immuno-diagnostics development company, initially focused on the kidney transplantation market. The Company’s kidney transplant assays use advanced next-generation sequencing that may define a personalised, risk-profile of each patient over the course of their transplant journey, as well as may detect injury in advance of currently available clinical tests.
Russ Mould, Investment Director at stockbroker AJ Bell talks about activist investors, specifically Elliott Management who have taken a multi-billion pound stake in Glaxosmithkline #GSK
(Interview starts 18 minutes 54 seconds)
Glen Goodman, former ITV News Business correspondent and now author of, "The Crypto Trader", covers this week’s Bitcoin, Blockchain and Cryptocurrency news.
(Interview starts 31 minutes 34 seconds)
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.